ATC Group: B01AC07 Dipyridamole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of B01AC07 in the ATC hierarchy

Level	Code	Title
`1`	B	Blood and blood forming organs
`2`	B01	Antithrombotic agents
`3`	B01A	Antithrombotic agents
`4`	B01AC	Platelet aggregation inhibitors excl. heparin
`5`	B01AC07	Dipyridamole

Defined daily dose

The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. The DDD is a unit of measurement and does not necessarily reflect the recommended or Prescribed Daily Dose. Therapeutic doses for individual patients and patient groups will often differ from the DDD as they will be based on individual characteristics (such as age, weight, ethnic differences, type and severity of disease) and pharmacokinetic considerations.

Code	Route	Amount	Notes
ORAL	Oral	0.4 g
PAREN	Parenteral	0.2 g

Active ingredients in B01AC07

Active Ingredient
Dipyridamole
Dipyridamole is an antithrombotic agent with antiplatelet activity. Dipyridamole has an antithrombotic action based on its ability to modify various aspects of platelet function, such as platelet aggregation, adhesion and survival, which are factors associated with the initiation of thrombus formation.

Related product monographs

Document	Type	Information Source
OFCRAM Prolonged release capsules, hard	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PERAZODIN Coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)
Persantin 100 mg Tablets	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
PERSANTINE Coated tablet	MPI, US: SPL/Old	FDA, National Drug Code (US)
PROCARDIN Film-coated tablet	MPI, EU: SmPC	Υπουργείο Υγείας (CY)